Tiny Adams
Psychiatric/Mental Health · Albuquerque, NMNPI 1669403218
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 286 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 286 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$909
- Neurocrine Biosciences, Inc.$549
- Teva Pharmaceuticals USA, Inc.$422
- Otsuka America Pharmaceutical, Inc.$259
- plus $1K from 15 others
What the payments were for
- Food & beverage$5,34497%
- Education$1583%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 53 | $1,054 |
| AbbVie | 61 | $1,038 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $909 |
| Neurocrine Biosciences, Inc. | 29 | $549 |
| Teva Pharmaceuticals USA, Inc. | 19 | $422 |
| Otsuka America Pharmaceutical, Inc. | 13 | $259 |
| Sunovion Pharmaceuticals Inc. | 12 | $207 |
| Johnson & Johnson | 8 | $171 |
| Axsome Therapeutics, Inc. | 8 | $164 |
| Vanda Pharmaceuticals Inc. | 7 | $156 |
| Corium, LLC | 9 | $134 |
| E.r. Squibb & Sons, L.L.C. | 5 | $92 |
| Lundbeck LLC | 5 | $89 |
| Gilead | 4 | $78 |
| Indivior Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Merck | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,503 in reported general payments places this provider in the 95th percentile of 228 psychiatric/mental health providers in New Mexico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 37 | $57,518 |
| Abilify MaintenaAripiprazole | 16 | $38,743 |
| Aripiprazole | 35 | $2,823 |
| Vilazodone Hcl | 16 | $1,500 |
| Trazodone Hcl | 149 | $922 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $792 |
| Paliperidone ErPaliperidone | 11 | $727 |
| Quetiapine Fumarate | 73 | $679 |
| Clonazepam | 70 | $645 |
| Olanzapine | 39 | $537 |
| Duloxetine Hcl | 36 | $531 |
| Fluoxetine Hcl | 75 | $495 |
| Mirtazapine | 51 | $493 |
| Divalproex Sodium | 31 | $472 |
| Hydroxyzine Pamoate | 29 | $418 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,038 | $57,51837 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $259 | $38,74316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 228 psychiatric/mental health providers in New Mexico.
Other psychiatric/mental health in Albuquerque
- Martha SnowAlbuquerque$13K
- Rhodah SimiyuAlbuquerque$4K
- Melissa LeuzziAlbuquerque$4K
- Petra Lamla LabanAlbuquerque$3K
- Jennifer ClysdaleAlbuquerque$3K
- Diane ElmanAlbuquerque$2K
- Bryan KrummAlbuquerque$2K
- Charlotte NkwentiAlbuquerque$2K
- Desiree ProvencioAlbuquerque$2K
- Denis MuebakeAlbuquerque$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.